(Central Standard Time)
(Central Standard Time)
9:15 am - 10:45 am
Session
Autonomic Disorders in Your NM Practice: How to Identify and Treat Them - Part 1
Identify peripheral autonomic disorders and common studies done in a typical NM practice, encompassing diabetic, amyloid, autoimmune autonomic neuropathy, and those associated with small fiber neuropathy; correctly interpret testing; identify patterns per disease, and provide patients with available treatments including for orthostatic hypotension.
Q & A will take place for both Autonomic Disorders in Your NM Practice sessions at the end of Part 2.
1.50CME/CEU
Jasvinder P. Chawla, MBBS, MD, MBA, FAAN | Amanda C. Peltier, MD, MS
9:15 am - 10:45 am
Session
US Assessment of MSK Mimics
Identify common MSK conditions that could clinically mimic focal neuropathies; distinguish peripheral nerve and MSK pathology; and identify through clinical cases using US and EDX how to distinguish potential MSK abnormalities from focal neuropathies.
1.50CME/CEU
Jeffrey A. Strakowski, MD
9:15 am - 10:45 am
Session
Basic: EMG Study Design
Participants will summarize the design of the electrodiagnostic evaluation; demonstrate how to perform the tests chosen; interpret the resulting data; and compose a meaningful report.
1.50CME/CEU
John C. Kincaid, MD | Rebecca A. O'Bryan, MD | Sara Takacs, MD
12:15 pm - 1:45 pm
Session
Autonomic Disorders in Your NM Practice: How to Identify and Treat Them - Part 2
Identify peripheral autonomic disorders in a typical NM practice, encompassing diabetic, amyloid, autoimmune autonomic neuropathy, and those associated with small fiber neuropathy; correctly interpret testing; identify patterns per disease, and provide patients with available treatments including for orthostatic hypotension.
1.50CME/CEU
Mohamed Kazamel, MD
12:15 pm - 1:45 pm
Session
Channelopathies in NMDs
Appraise the clinical presentations, genetics, and treatment of periodic paralysis; distinguish between sub-types of periodic paralysis on clinical grounds (history, specific triggers, etc.) and articulate prophylactic treatments and potential pitfalls; and recognize when and how to perform an ancillary examination (ictal serum potassium, EMG, genetics) when evaluating a patient with periodic paralysis.
1.50CME/CEU
Jau-Shin Lou, MD, PhD, MBA | Mohammad K. Salajegheh, MD | Jaya R. Trivedi, MD
12:15 pm - 1:45 pm
Session
US Guided Procedures
Describe the role of US to enhance the safety and accuracy of various diagnostic and interventional procedures performed in the EMG lab and outpatient practice settings; identify techniques to facilitate accurate needle placement for EMG of high-risk structures; define various perineural and intramuscular procedures for the treatment of peripheral nerve pain, including carpal tunnel syndrome, ulnar neuropathy, meralgia paresthetica, and thoracic outlet syndrome.
1.50CME/CEU
Einar Ottestad | Sarada Sakamuri, MD | Jeremy Stanek, MD
2:00 pm - 3:30 pm
Session
Basic: Nerve Conduction Studies
A basic session aimed at residents/fellows/new EDX physicians. Participants will learn to approach patients with upper or lower limb symptoms and plan their NCS tests. Brief review of techniques for nerve conduction studies (NCS) will be presented and how results help with each diagnosis. Interpretation of patterns of abnormality in clinical context will be explored.
1.50CME/CEU
Michael T. Andary, MD, MS | Sandra L. Hearn, MD | Vikram Narula, MD
2:00 pm - 3:30 pm
Session
Teleneurology & Technology in NM
Explain the current technology in teleneurology; identify barriers in use of technology in practice of NM medicine; and discuss an current practice models of teleNM medicine.
1.50CME/CEU
Raghav Govindarajan, MD | Michael T. Pulley, MD, PhD | Madhu Soni, MD
Tuesday | March 2
(Central Standard Time)
9:15 am - 10:45 am
Session
Basic NCS: Axonal, Demyelinating, or Anomaly
Explain the basic pathophysiology of axon loss, demyelination, and conduction block; identify the corresponding nerve conduction patterns for axonal and demyelinating processes; recognize the most common anomalous innervations in the upper and lower limbs; describe the nerve conduction techniques used to confirm the presence of an anomalous innervation.
This is a Self-Assessment (SA) CNCT Checkpoint session. To receive the SA CNCT Checkpoint credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.
1.50CME/CEU
Alexis E. Nelson, MD | Daniel B. Simmons, MD
9:15 am - 10:45 am
Session
Clinical Manifestation and Diagnosis of MG
Identify the clinical manifestations of various subtypes of MG; select appropriate diagnostic approaches for confirming the diagnosis of MG; discuss the differential diagnoses of MG.
1.50CME/CEU
Michael K. Hehir, MD | Yuebing Li, MD, PhD | Mamatha Pasnoor, MD
9:15 am - 10:45 am
Session
NM US to Guide Operative Management: What our Surgeons Really Want to Know
At the end of the session attendees will be able to incorporate NM US for surgical planning; identify pitfalls of routine EDX studies in trauma patients; utilize US to enhance their EDX study; will be better able to explain the advantages of US compared to other imaging modalities; will be able to explain and identify the appearance of injured nerves and painful neuromas that are often the target of surgical intervention; will be better able to explain the anatomic variability of peripheral nerves and how US can be used to guide surgical planning; will be able to use US to identify important structures for surgical planning, to include muscles and tendons used for both motor branch and tendon transfer surgeries; apply dynamic US assessments of muscles and nerves that can applied for preoperative planning and postoperative evaluation.
1.50CME/CEU
Matthew E. Miller, MD | Sarada Sakamuri, MD | Jason Souza, MD
12:15 pm - 1:45 pm
Session
Horses, Zebras, & Unicorns: Interactive Case Based Update Common/Not So Common NMDs-Pt 1
As it relates to common and unusual nerve and muscle disorders, articulate clinical characteristics of these disorders; recognize the role of EDX testing, genetic testing, serological studies, and biopsy for diagnosing and evaluating patients; and utilize PNS anatomy to help facilitate clinical evaluation and treatment in complex patients.
1.50CME/CEU
Suur Biliciler, MD | Justin Y. Kwan, MD | Anishee Undavia, MD
12:15 pm - 1:45 pm
Session
Genetic Muscle Disorders
Identify the diversity of genetic muscle disorders; recognize an effective diagnostic algorithm for patients with genetic muscle disease; recall the current and future optimal management and treatment of genetic muscle disease.
1.50CME/CEU
Eric Pozsgai | Jeffrey Statland, MD | Matthew P. Wicklund, MD
12:15 pm - 1:45 pm
Session
The Use of Multiple Testing Modalities in Challenging NM Cases
Identify testing modalities that can help in the diagnosis and management of challenging NM patients; determine the clinical significance of unusual laboratory tests; articulate basics of muscle MRI and its role in diagnosing challenging NM cases.
1.50CME/CEU
Namita Goyal, MD | Chafic Karam, MD | Elie Naddaf, MD
Wednesday | March 3
(Central Standard Time)
2:00 pm - 3:30 pm
Session
Horses, Zebras, & Unicorns: Interactive Case Based Update Common/Not So Common NMDs-Pt 2
As it relates to common and unusual nerve and muscle disorders, articulate clinical characteristics of these disorders; recognize the role of EDX testing, genetic testing, serological studies, and biopsy for diagnosing and evaluating patients; and utilize PNS anatomy to help facilitate clinical evaluation and treatment in complex patients.
This is a Self-Assessment (SA) CME session. To receive the SA CME credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.
1.50CME/CEU
Ryan D. Jacobson, MD | Justin Y. Kwan, MD | Dustin Nowacek, MD
2:00 pm - 3:30 pm
Session
EDX Approach for Plexopathies
This course will provide an approach for physicians to evaluate and diagnose lesions involving the brachial and lumbar plexus. Relevant anatomy and differential diagnosis including potential mimics from other neurological conditions will be discussed. Case-based review will provide a thorough step-by-step approach to interpret EDX information in order to make a diagnosis. Finally, a brief summary of surgical options based on the EDX diagnosis and prognosis will be introduced.
Goals include: Recognize the anatomy of the brachial and lumbar plexus; develop a differential diagnosis for causes of brachial and lumbar plexopathies; identify other neurological conditions that can mimic plexopathies; interpret EDX studies in a systematic fashion to precisely localize the lesion(s).
1.50CME/CEU
Joelle Gabet, MD | Shawn Jorgensen, MD | Michael C. Munin, MD
Wednesday | March 3
Buy the Spring Conference Collection
Purchasing the Spring Conference Collection gives you access to the conference content and credit claiming
until March 2024.
Buy the collection before March 2 for just $100!
(Central Standard Time)
9:15 am - 10:45 am
Session
Updates of Demyelinating Neuropathies
Convey the criteria for identifying demyelination on NCS and articulate the presentation, diagnosis, and treatment of GBS and CIDP.
This is a technologist focused session. Anyone who has interest in this topic is welcome to attend.
1.50CME/CEU
Shawn Bird, MD | Grace C. Kimbaris, MD
9:15 am - 10:45 am
Session
MG Therapy and Novel Approaches
This session will be divided into two portions. The first will cover the treatment approach to MG to include the role of thymectomy and MG. The second will focus on emerging therapies in MG highlighting recent advances in the field.
1.50CME/CEU
Amanda C. Guidon, MD | Kelly G. Gwathmey, MD
9:15 am - 10:45 am
Session
EDX Clinical and Laboratory Evaluation of Polyneuropathy
Recognize the clinical features of the major types of peripheral neuropathy; assess how electrodiagnostic studies can help to differentiate the major subtypes of polyneuropathy; to identify which laboratory and ancillary tests are most useful in the evaluation of polyneuropathy.
1.50CME/CEU
Rima El-Abassi, MD | John D. England, MD | Maxwell H. Levy, MD
12:15 pm - 1:45 pm
Session
ALS
Summarize our current knowledge on ALS pathology; apply EMG skills to support an ALS diagnosis and exclude mimickers; identify and discuss approved drugs for ALS; summarize treatments in development for ALS.
1.50CME/CEU
Jennifer M. Martinez-Thompson, MD | Bjorn E. Oskarsson, MD | Nathan P. Staff, MD, PhD
12:15 pm - 1:45 pm
Session
Infection and Immunization in NM Disorders with emphasis on COVID-19
Describe the spectrum of NM conditions associated with infections and vaccinations, define vaccination and immunization, discuss vaccinations for patients with autoimmune and non-autoimmune NM disorders, discuss vaccinations for patients with altered immunocompetence, discuss infection prophylaxis for patients with neuromuscular disorders, describe NM conditions associated with COVID-19, discuss COVID-19 vaccination for patients with NM disorders
This is a Self-Assessment (SA) CME session. To receive the SA CME credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.
1.50CME/CEU
Gregory Gruener, MD, MBA, MHPE | Pushpa Narayanaswami, MBBS, DM | Sasha Zivkovic, MD PhD
12:15 pm - 1:45 pm
Session
Disorders of Peripheral Nerve and Muscle Hyperexcitability
Attendees will be better able to classify and identify causes of nerve and muscle hyperexcitability; diagnose and manage myotonic disorders and other causes of muscle hyperexcitability; identify and manage stiff person syndrome and peripheral nerve hyperexcitability.
This is a Self-Assessment (SA) CME session. To receive the SA CME credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.
1.50CME/CEU
Goran Rakocevic, MD | Mohammad K. Salajegheh, MD
2:00 pm - 3:30 pm
Session
EDX of Radiculopathy
Participants will be able to outline the approach to the EDX evaluation of cervical and lumbosacral radiculopathies including differential diagnoses considered, muscle selection, paraspinal muscle mapping, and the sensitivity and specificity of EDX studies; discuss the significance of anomalous innervations and their impact on EDX findings; and we will also critically examine the evidence for the utility of EDX studies in predicting response to epidural steroid injections and surgery.
1.50CME/CEU
Daniel Cushman, MD | Kyle Mahoney, MD | Ligia V. Onofrei, MD
Thursday | March 4
(Central Standard Time)
2:00 pm - 3:30 pm
Session
Quality Improvement, Performance Measurement and Patient Safety in Electrodiagnosis and NM Disease
Define value in healthcare, describe the evolution of quality measurement in healthcare, explain the components of a quality measure and apply quality measurement in practice; define adverse events, explain individual and systems errors leading to adverse events, discuss the structure of common formal root cause analyses methods and apply these methods in incident monitoring platforms such as mortality and morbidity conferences.
This is a Self-Assessment (SA) CME session. To receive the SA CME credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.
1.50CME/CEU
John C. Kincaid, MD | Pushpa Narayanaswami, MBBS, DM | Teryl Nuckols, MD, MSHS | Sasha Zivkovic, MD PhD
Thursday | March 4
AANEM 2021 Annual MeetingSave the date for the 2021 Annual Meeting in Aurora, Colorado, October 13-16.Learn from leaders in NM and EDX medicine from across the world.
The current plan is to hold the meeting in person, but the AANEM continues to monitor the rapidly changing COVID-19 pandemic and will adjust the meeting plans accordingly.
(Central Standard Time)
9:15 am - 10:45 am
Session
Clinical Approach to Progressive Generalized Weakness in Adults
Rapidly growing targeted small molecule treatments, gene therapy trials and novel genetic discoveries are starting to revolutionize the management of neuromuscular disorders resulting in progressive generalized muscle weakness. Therefore, it is prudent to take a systematic approach for evaluating a patient with generalized/multisegmental weakness and recognize and differentiate the phenotypic patterns, confirm molecular diagnoses and expedite patient access to FDA approved and experimental therapies. Focused clinical history, examination and focused yet thorough diagnostic workup have become the cornerstone of such an approach. Faculty will present phenotypic patterns, diagnostic algorithms and easy to use tools and management strategies in a case-based approach.
1.50CME/CEU
Suma Babu, MBBS, MPH | Paloma Gonzalez Perez, MD, PhD | Bjorn E. Oskarsson, MD | Shruti Raja, MD
9:15 am - 10:45 am
Session
Fascicular Anatomy of the Nerve and Nerve Injuries Updated With Ultrahigh Frequency MSK US
Revisit the fascicular anatomy of the nerve from 50 years history by Sydney Sunderland with high frequency US techniques.
This is a Special Interest Group Session. Anyone who has interest in this topic is welcome to attend.
1.50CME/CEU
Rachana Gandhi, MD | Jeffrey A. Strakowski, MD | Faye Y. Tan, MD
9:15 am - 10:45 am
Session
Transitioning the Child to Adult NM Care
Become familiar with the most common life-long NMD that fail to transition to adult NM care; identify the factors that impact the ability of a patient to transition from pediatric to adult NM care; recognize effective approaches to facilitate successful transition of a NMD patient.
This is a Special Interest Group Session. Anyone who has interest in this topic is welcome to attend.
1.50CME/CEU
Ericka P. Greene , MD | Gabrielle Nguyen, MD | Lydia J. Sharp, MD | Cynthia Wozow, DO
Friday | March 5
Attend an Industry Forum – You Could Win $1000By attending an Industry Forum,
you’ll be entered for a chance to win a $1,000 Visa gift card!
Spread the Word About Our New APP Webinar Series
Every Wednesday from May 19 – June 23
Attendees will learn how to perform a detailed NM exam and when to order an
EDX study.
Help us spread the word to your APP colleagues!
(Central Standard Time)
RARENEUROLOGICALDISEASE SPECIAL REPORT
M
AR
CH
2020
RA
RE
NE
UR
OL
OG
ICA
L D
ISEA
SE SP
EC
IAL
RE
PO
RT
S
UP
PL
EM
EN
T T
O N
EU
RO
LO
GY
RE
VIE
WS
26 I Angelman Syndrome:
Etiology, Diagnosis,
Management, and Novel
Treatments
38 I What Can Phenotypic
Variation Tell Us About
Amyotrophic Lateral
Sclerosis?
76 I NDC Symposium
Highlights Recent
Advances in Pediatric
Neuro-Oncology
90 I Duchenne Muscular
Dystrophy: Making the
Diagnosis and Providing
Lifelong Care
104 I The Evolving
Landscape of Mitochondrial
Disease Management
IN THIS ISSUE
A SUPPLEMENT TO NEUROLOGY REVIEWS
RARENEUROLOGICALDISEASE SPECIAL REPORT
A Member of the Network
MARCH 2 020
NR_NORD_2020_Cover_Spine_Final_REV_CL.indd 1
2/27/20 10:17 AM
M
AR
CH
2020
RA
RE
NE
UR
OL
OG
ICA
L D
ISEA
SE SP
EC
IAL
RE
PO
RT
SU
PP
LE
ME
NT
TO
NE
UR
OL
OG
Y R
EV
IEW
S
26 I Angelman Syndrome: Etiology, Diagnosis, Management, and Novel
Treatments
38 I What Can Phenotypic Variation Tell Us About Amyotrophic Lateral Sclerosis?
76 I NDC Symposium Highlights Recent Advances in Pediatric Neuro-Oncology90 I Duchenne Muscular Dystrophy: Making the Diagnosis and Providing
Lifelong Care104 I The Evolving Landscape of Mitochondrial
Disease Management
IN THIS ISSUE
A SUPPLEMENT TO NEUROLOGY REVIEWS
RARENEUROLOGICALDISEASE SPECIAL REPORT
A Member of the Network
MARCH 2020
NR_NORD_2020_Cover_Spine_Final_REV_CL.indd 1
2/27/20 10:17 AM
M
AR
CH
2020
RA
RE
NE
UR
OL
OG
ICA
L D
ISEA
SE SP
EC
IAL
RE
PO
RT
S
UP
PL
EM
EN
T T
O N
EU
RO
LO
GY
RE
VIE
WS
26 I Angelman Syndrome: Etiology, Diagnosis, Management, and Novel Treatments
38 I What Can Phenotypic Variation Tell Us About Amyotrophic Lateral Sclerosis?
76 I NDC Symposium Highlights Recent Advances in Pediatric Neuro-Oncology
90 I Duchenne Muscular Dystrophy: Making the Diagnosis and Providing Lifelong Care
104 I The Evolving Landscape of Mitochondrial Disease Management
IN THIS ISSUE
A SUPPLEMENT TO NEUROLOGY REVIEWS
RARENEUROLOGICALDISEASE SPECIAL REPORT
A Member of the Network
MARCH 2 020
NR_NORD_2020_Cover_Spine_Final_REV_CL.indd 1
2/27/20 10:17 AM
In celebration of Rare Disease Day— February 28, 2021 and the success of previous Special Reports, Neurology Reviews, in collaboration with the National Organization for Rare Disorders (NORD) will publish our 7th annual Rare Neurological Disease Special Report.
• Advertising in this Special Report will provide your corporate or brand message with a powerful multichannel platform within timely and relevant editorial content.
• The editorial content will be developed by Neurology Reviews and NORD and will include rare disease information, medical conference coverage, and exclusive interviews with rare disease experts.
• The Special Report will be converted into a digital edition (electronic magazine) and hosted on the Neurology Reviews website for 12 months to provide advertisers with additional reach and visibility.
Coming Soon
https://www.neurologyreviews-digital.com /neurologyreviews/nord_march_2020
FOR MORE INFORMATION, CONTACT:
Elizabeth Katz, Publisher I Neurology Reviews I [email protected] I 973-224-7951
Toni Haggerty, Senior Director of Business Development I Neurology Reviews
[email protected] I 856-296-5705
APRIL 2021
(Central Standard Time)
2621 Superior Drive NWRochester, MN 55901
Top Related